RECRUITING

Ultrasound Guided Femoral Nerve Block

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.

Official Title

Comparison of Ultrasound Guided Femoral Nerve Blockade and Standard Parenteral Opioid Pain Management Alone in Patients With Hip Fracture in the Emergency Department

Quick Facts

Study Start:2015-08
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02381717

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 101 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients over 18 years of age presenting to the ED with radiographically established intra-, extracapsular hip fracture, able to consent and participate in the study and who have moderate to severe pain (numerical pain score \>= 31) at the time of enrollment.
  1. * Patients with a previous history of hypersensitivity to local anesthetics,
  2. * Patients who have signs of a local infection at the site of planned needle placement.
  3. * INR \> 1.4NOAC use within 48 hours
  4. * Prophylactic Low-Molecular Weight Heparin (LMWH) within 12 hours
  5. * Therapeutic LMWH within 24 hours
  6. * Prophylactic Unfractionated Heparin (5000 Units BID or TID) within 6 hours

Contacts and Locations

Study Contact

Beatrice Hoffmann, MD PhD
CONTACT
617-754-2323
bhoffma2@bidmc.harvard.edu
Elinita Rosseto
CONTACT
617-754-2332
erosseto@bidmc.harvard.edu

Principal Investigator

Beatrice Hoffmann, MD PhD
PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical

Study Locations (Sites)

Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
United States
St. Vincent's Hospital
Worcester, Massachusetts, 01608
United States

Collaborators and Investigators

Sponsor: Beth Israel Deaconess Medical Center

  • Beatrice Hoffmann, MD PhD, PRINCIPAL_INVESTIGATOR, Beth Israel Deaconess Medical

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-08
Study Completion Date2026-12

Study Record Updates

Study Start Date2015-08
Study Completion Date2026-12

Terms related to this study

Keywords Provided by Researchers

  • ultrasound
  • bupivacaine
  • femoral nerve block
  • pain reduction

Additional Relevant MeSH Terms

  • Hip Fracture